Discontinuation report ULORIC

Last updated on 2022-01-04 History
Report ID 144266
Drug Identification Number 02357380
Brand name ULORIC
Common or Proper name ULORIC 80 mg Tablets
Company Name TAKEDA CANADA INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) FEBUXOSTAT
Strength(s) 80MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size Bottle of 30's
ATC code M04AA
ATC description ANTIGOUT PREPARATIONS
Reason for discontinuation Business reasons
Anticipated discontinuation date 2021-12-31
Actual discontinuation date 2021-12-31
Remaining supply date 2021-12-31
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 22 ADELAIDE STREET WEST
TORONTO, ONTARIO
CANADA M5H 4E3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2022-01-04 French Compare
v3 2022-01-04 English Compare
v2 2021-08-17 French Compare
v1 2021-08-17 English Compare

Showing 1 to 4 of 4